EX-13.1 6 f20f2022ex13-1_gmedical.htm CERTIFICATION

Exhibit 13.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350

 

In connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2022 (the “Report”) by G Medical Innovations Holdings Ltd. (the “company”), the undersigned, as the Chief Executive Officer of the company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the company.

 

Date: May 16, 2023 /s/ Yacov Geva
  Yacov Geva
  Chief Executive Officer